The drug industry’s new tactic in Washington: calling Trump’s bluff - STAT

The drug industry’s new tactic in Washington: calling Trump’s bluff - STAT

STAT Plus: The drug industry’s new tactic in Washington: calling Trump’s bluff 

By NICHOLAS FLORKO AND LEV FACHER

ALEX WONG/GETTY IMAGES

Pharma is skipping White House meetings and publicly questioning Trump’s resolve — a brazen new strategy for dealing with his efforts to lower drug prices. 

READ MORE